| TAC04303 |
(S)-HH2853 |
|
98%+ |
| TAC04295 |
AM-9747 |
|
98%+ |
| TAC04307 |
AMG-176 |
|
98%+ |
| TAC04286 |
Basroparib (STP1002) |
|
98%+ |
| TAC04292 |
BDTX-1535 |
EGFR-IN-76 (compound 37A) is a potent inhibitor of EGFR[1]. |
98%+ |
| TAC04309 |
BTKinhibitor1(Compound27) |
|
98%+ |
| TAC04302 |
CDK7-IN-21 (compound A22) |
|
98%+ |
| TAC04290 |
CPD-1224 |
|
98%+ |
| TAC04294 |
DJ4 |
|
98%+ |
| TAC04291 |
EP4-IN-1 |
|
98%+ |
| TAC04285 |
Fostroxacitabine bralpamide (MIV-818) |
|
98%+ |
| TAC04293 |
I-138 |
|
98%+ |
| TAC04299 |
IDE397 (GSK-4362676) |
|
98%+ |
| TAC04297 |
IK-930 |
|
98%+ |
| TAC04288 |
ITF3756 |
|
98%+ |
| TAC04279 |
KRAS G12C inhibitor 19 |
|
98%+ |
| TAC04280 |
LY3410738 |
|
98%+ |
| TAC04287 |
MSU-42011 |
|
98%+ |
| TAC04308 |
PD-1-IN-1 |
|
98%+ |
| TAC04298 |
PDS-0330 |
|
98%+ |
